Table 1 Summary of clinical presentation, treatment and outcome of both patients
Patient | Initial Diagnosis | Baseline CD4 Counts (cells/μL) | Initial Treatment | Time to IRIS (weeks) | Clinical Presentation | Event CD4 counts (cells/μL) | IRIS Treatment | Outcome | Time to Response (weeks) |
|---|---|---|---|---|---|---|---|---|---|
CASE I | HIV WHO stage II PPE | 4 | TDF/FTC/EFV Cotrimoxazole prophylaxis Cetirizine | 2 | Inflammatory lesions on upper limbs, face and trunk | 134a | Fluconazole Prednisolone Cetrizine | Complete response | 8 |
CASE II | HIV WHO Stage IV CAP Esophageal candidiasis | 1 | TDF/FTC/EFV Amoxicillin Fluconazole Cotrimoxazole prophylaxis | 7 | Inflammatory lesions on upper limbs, face and trunk | 188 | Griseofulvin, Prednisolone Cetrizine | Complete response | 2 |